John B. Sanfilippo & Son, Inc. (JBSS) Balance Sheet

Retained earnings climbed from $187.0M to $226.4M over this period, which suggests internally generated capital is supporting the asset base rather than external equity issuance. However, the growth in total liabilities from $193.0M to $302.2M implies a meaningful share of asset expansion has been debt or payable funded, warranting attention to the durability of that funding mix. The trend appears to lean toward a strengthening equity base, though the trajectory is uneven quarter to quarter.

The peak of $148.7M in 2027Q1 coincides with rising inventory and receivables, which may indicate seasonal or working capital driven borrowing rather than structural leverage increases. A debt-to-equity ratio near 0.40 remains conservative, suggesting limited refinancing pressure, though investors should monitor whether the recent upswing reverses as operating cash conversion normalizes. The data does not clarify the maturity profile or covenant terms, so the refinancing risk cannot be fully assessed from these figures.

Cash balances have remained below $2.5M across all ten quarters, which suggests the company operates with minimal idle liquidity and likely depends on revolving facilities to manage intra-period needs. A current ratio consistently above 1.8 indicates current assets comfortably cover current obligations on paper, though the quality of those assets, particularly inventory tied to agricultural commodities, warrants scrutiny. Investors should monitor whether working capital absorption continues to strain near-term liquidity.

The step-up in PPE may reflect capacity investment consistent with the company's processing footprint, though the 2027Q1 reading of $41.4M implies a sharp reclassification or data inconsistency that should be verified against filings. The stable goodwill balance indicates limited acquisition-driven intangible exposure, reducing impairment risk. Asset quality appears tilted toward physical plant, which may support long-term operations but also means fixed-cost absorption remains a sensitivity.